Medical Xpress September 13, 2025
The U.S. Food and Drug Administration is taking new steps to regulate direct-to-consumer drug advertisements and eliminate misleading advertisements out of concern that patients are not receiving a “fair balance” of information on pharmaceutical products.
“For far too long, the FDA has permitted misleading drug advertisements, distorting the doctor-patient relationship and creating increased demand for medications regardless of clinical appropriateness,” FDA Commissioner Marty Makary, M.D., M.P.H., said in a statement.
This week, the agency announced it sent out thousands of letters to pharmaceutical companies warning them to remove misleading ads. About 100 cease-and-desist letters were also sent to companies that the FDA determined have “deceptive” ads.
This is in contrast to only one warning letter that was sent in 2023...
Today's Sponsors
Today's Sponsor